These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22564737)

  • 21. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
    Ling YX; Tao J; Fang SF; Hui Z; Fang QR
    Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein.
    Loveys DA; Streiff MB; Kato GJ
    Nucleic Acids Res; 1996 Jul; 24(14):2813-20. PubMed ID: 8759016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
    Okuya M; Kurosawa H; Kikuchi J; Furukawa Y; Matsui H; Aki D; Matsunaga T; Inukai T; Goto H; Altura RA; Sugita K; Arisaka O; Look AT; Inaba T
    J Biol Chem; 2010 Jan; 285(3):1850-60. PubMed ID: 19887369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells.
    Nigten J; Breems-de Ridder MC; Erpelinck-Verschueren CA; Nikoloski G; van der Reijden BA; van Wageningen S; van Hennik PB; de Witte T; Löwenberg B; Jansen JH
    Leukemia; 2005 May; 19(5):799-805. PubMed ID: 15744343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.
    De Luca P; Vazquez ES; Moiola CP; Zalazar F; Cotignola J; Gueron G; Gardner K; De Siervi A
    Mol Cancer Res; 2011 Aug; 9(8):1078-90. PubMed ID: 21700680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
    Lietz A; Janz M; Sigvardsson M; Jundt F; Dörken B; Mathas S
    Br J Haematol; 2007 May; 137(4):342-8. PubMed ID: 17456056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2A promotes the survival of precursor and mature B lymphocytes.
    Lazorchak AS; Wojciechowski J; Dai M; Zhuang Y
    J Immunol; 2006 Aug; 177(4):2495-504. PubMed ID: 16888011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
    Barrett CS; Millena AC; Khan SA
    Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
    Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
    Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori regulates the expression of inhibitors of DNA binding (Id) proteins by gastric epithelial cells.
    Manzo BA; Crabtree JE; Fiona Campbell M; Tweedle D; Potten CS; Bajaj-Elliott M; Sanderson IR; Wilson JW
    Microbes Infect; 2006 Apr; 8(4):1064-74. PubMed ID: 16473539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.
    Condorelli G; Vitelli L; Valtieri M; Marta I; Montesoro E; Lulli V; Baer R; Peschle C
    Blood; 1995 Jul; 86(1):164-75. PubMed ID: 7540882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors.
    Funato N; Ohtani K; Ohyama K; Kuroda T; Nakamura M
    Mol Cell Biol; 2001 Nov; 21(21):7416-28. PubMed ID: 11585922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells.
    Martinez LA; Yang J; Vazquez ES; Rodriguez-Vargas Mdel C; Olive M; Hsieh JT; Logothetis CJ; Navone NM
    Carcinogenesis; 2002 Aug; 23(8):1289-96. PubMed ID: 12151346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.
    Zhang JY; Li YN; Mu X; Pan ZL; Liu WB
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8599-8608. PubMed ID: 30575899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
    San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
    Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human calcium/calmodulin-dependent serine protein kinase regulates the expression of p21 via the E2A transcription factor.
    Sun R; Su Y; Zhao X; Qi J; Luo X; Yang Z; Yao Y; Luo X; Xia Z
    Biochem J; 2009 Apr; 419(2):457-66. PubMed ID: 19125693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB.
    Barndt RJ; Dai M; Zhuang Y
    Mol Cell Biol; 2000 Sep; 20(18):6677-85. PubMed ID: 10958665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2A attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathway.
    Zhao H; Zhao C; Li H; Zhang D; Liu G
    J Exp Clin Cancer Res; 2019 Jun; 38(1):276. PubMed ID: 31234887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
    Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
    Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.